urocanic acid has been researched along with Disease Exacerbation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Douglass, SM; Weeraratna, AT; Worrede, A | 1 |
| DeLuca, HF; Irving, AA; Marling, SJ; Plum, LA | 1 |
| Vincek, V | 1 |
1 review(s) available for urocanic acid and Disease Exacerbation
| Article | Year |
|---|---|
The dark side of daylight: photoaging and the tumor microenvironment in melanoma progression.
Topics: Aging; Animals; Disease Progression; Extracellular Matrix; Humans; Immune Tolerance; Melanins; Melanoma; Mice; Receptors, Aryl Hydrocarbon; Skin; Skin Aging; Skin Neoplasms; Tumor Microenvironment; Ultraviolet Rays; Urocanic Acid; Vitamin D | 2021 |
2 other study(ies) available for urocanic acid and Disease Exacerbation
| Article | Year |
|---|---|
Suppression of experimental autoimmune encephalomyelitis by ultraviolet light is not mediated by isomerization of urocanic acid.
Topics: Animals; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Isomerism; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Ultraviolet Rays; Ultraviolet Therapy; Urocanic Acid | 2017 |
Sunlight induced progression of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Animals; Disease Progression; Epidermis; HIV; Humans; Immune Tolerance; Immunocompetence; Mice; Models, Immunological; Prostaglandins E; Sunlight; Th2 Cells; Tumor Necrosis Factor-alpha; Ultraviolet Rays; Urocanic Acid; Virus Activation | 1995 |